Sees FY25 adjusted EBITDA loss $5M-$9M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMDA:
- Omada Health reports Q2 EPS (24c), consensus (13c)
- Omada Health’s Strategic Partnerships and AI Leverage Drive Growth and Profitability Outlook
- Omada Health, Inc.: A Promising Buy Amid Technical Weakness and Growth Potential
- Goldman Sachs Beats the Drum on These 2 ‘Strong Buy’ Stocks
- Nike upgraded, Sportradar initiated: Wall Street’s top analyst calls